Published in J Am Acad Dermatol on September 01, 1999
Therapy of pruritus. Expert Opin Pharmacother (2010) 0.93
Pruritus: management algorithms and experimental therapies. Semin Cutan Med Surg (2011) 0.90
Opiate-mediated pruritus and citation etiquette. J Am Acad Dermatol (2000) 0.75
Assessment of the Visual Analogue Score in the Evaluation of the Pruritus of Cholestasis. J Clin Transl Hepatol (2017) 0.75
A comparison of amphotericin B alone and combined with flucytosine in the treatment of cryptoccal meningitis. N Engl J Med (1979) 5.87
Oxidation of biphenyl by a Beijerinckia species. Biochem Biophys Res Commun (1973) 4.90
An antigenic analysis of respiratory syncytial virus isolates by a plaque reduction neutralization test. Am J Epidemiol (1966) 3.72
Hemagglutinin-specific enzyme-linked immunosorbent assay for antibodies to influenza A and B viruses. J Clin Microbiol (1981) 3.46
Dihydrodiols from anthracene and phenanthrene. J Am Chem Soc (1976) 3.45
A study of excess mortality during influenza epidemics in the United States, 1968-1976. Am J Epidemiol (1981) 3.27
Treatment of hereditary angioedema with danazol. Reversal of clinical and biochemical abnormalities. N Engl J Med (1976) 2.96
The mechanism of intestinal uptake and transcellular transport of IgG in the neonatal rat. J Clin Invest (1972) 2.88
Treatment of chronic non-A,non-B hepatitis with recombinant human alpha interferon. A preliminary report. N Engl J Med (1986) 2.85
Itch: scratching more than the surface. QJM (2003) 2.75
Glycophorin B as an EBA-175 independent Plasmodium falciparum receptor of human erythrocytes. Mol Biochem Parasitol (1994) 2.67
Age-specific prevalence of antibodies to hepatitis A and E viruses in Pune, India, 1982 and 1992. J Infect Dis (1995) 2.63
A new one-step method for the functional assay of the fourth component (C4) of human and guinea pig complement. J Immunol (1974) 2.60
Human T-cell recognition of the circumsporozoite protein of Plasmodium falciparum: immunodominant T-cell domains map to the polymorphic regions of the molecule. Proc Natl Acad Sci U S A (1988) 2.60
Abnormal signal intensity in skeletal muscle at MR imaging: patterns, pearls, and pitfalls. Radiographics (2000) 2.40
The genetic control of HLA-A and B antigens in somatic cell hybrids: requirement for beta2 microglobulin. Tissue Antigens (1978) 2.40
Colchicine therapy for familial mediterranean fever. A double-blind trial. N Engl J Med (1974) 2.35
The beta2-microglobulin gene is on chromosome 15 and not in the HL-A region. Nature (1975) 2.29
Antibody to hepatitis B core antigen as a paradoxical marker for non-A, non-B hepatitis agents in donated blood. Ann Intern Med (1986) 2.27
Antigenic relatedness between glycoproteins of human respiratory syncytial virus subgroups A and B: evaluation of the contributions of F and G glycoproteins to immunity. J Virol (1987) 2.26
Inhibition of mitogen-activated protein kinase kinase blocks T cell proliferation but does not induce or prevent anergy. J Immunol (1998) 2.18
Treatment of chronic mucocutaneous candidiasis with ketoconazole: a controlled clinical trial. Ann Intern Med (1980) 2.14
A comparison of the frequency of hepatitis-B antigen and antibody in hospital and nonhospital personnel. N Engl J Med (1973) 2.05
Seroconversion from hepatitis B e antigen to antibody in chronic type B hepatitis. Ann Intern Med (1981) 1.96
Serial cardiovascular variables in survivors and nonsurvivors of human septic shock: heart rate as an early predictor of prognosis. Crit Care Med (1987) 1.89
Systematic review: hepatitis-associated aplastic anaemia--a syndrome associated with abnormal immunological function. Aliment Pharmacol Ther (2009) 1.83
The role of cell-surface receptors in the transport and catabolism of immunoglobulins. Ciba Found Symp (1972) 1.80
Effect of age and preexisting antibody on serum antibody response of infants and children to the F and G glycoproteins during respiratory syncytial virus infection. J Clin Microbiol (1986) 1.79
Use of the enzyme-linked immunosorbent assay to detect serum antibody responses of volunteers who received attenuated influenza A virus vaccines. Infect Immun (1980) 1.77
Randomized, controlled trial of recombinant human alpha-interferon in patients with chronic hepatitis B. Gastroenterology (1988) 1.74
Epsilon aminocaproic acid therapy of hereditary angioneurotic edema. A double-blind study. N Engl J Med (1972) 1.73
Reactivation of chronic hepatitis B virus infection by cancer chemotherapy. Ann Intern Med (1982) 1.67
Histopathology and prognosis of malignant colorectal polyps treated by endoscopic polypectomy. Gut (1984) 1.66
The Budd-Chiari syndrome: correlation between hepatic scintigraphy and the clinical, radiological, and pathological findings in nineteen cases of hepatic venous outflow obstruction. Gastroenterology (1975) 1.66
Genetic regulation of protective immune response in congenic strains of mice vaccinated with a subunit malaria vaccine. J Immunol (1996) 1.60
Elevated brain concentrations of 1,4-benzodiazepines in fulminant hepatic failure. N Engl J Med (1991) 1.59
A controlled trial of HA-1A in a canine model of gram-negative septic shock. JAMA (1993) 1.59
The chronic sequelae of non-A, non-B hepatitis. Ann Intern Med (1979) 1.54
Synthesis of antibodies to hepatitis B virus by cultured lymphocytes from chronic hepatitis B surface antigen carriers. J Clin Invest (1983) 1.52
Trimethoprim-sulfamethoxazole prophylaxis in the management of chronic granulomatous disease. J Infect Dis (1990) 1.49
Receptor specific clearance by the reticuloendothelial system in chronic liver diseases. Demonstration of defective C3b-specific clearance in primary biliary cirrhosis. J Clin Invest (1978) 1.45
Interleukin 2 receptor expression in unstimulated murine splenic T cells. Localization to L3T4+ cells and regulation by non-H-2-linked genes. J Exp Med (1986) 1.44
Inhibition of MAP kinase kinase prevents cytokine and prostaglandin E2 production in lipopolysaccharide-stimulated monocytes. J Immunol (1998) 1.43
Genetics and serology of HL-A-linked human Ia antigens. Cold Spring Harb Symp Quant Biol (1977) 1.42
Kinetics of the antibody response to type III pneumococcal polysaccharide. I. Evidence that suppressor cells function by inhibiting the recruitment and proliferation of antibody-producing cells. J Immunol (1976) 1.42
Use of an X-linked human neutrophil marker to estimate timing of lyonization and size of the dividing stem cell pool. J Clin Invest (1985) 1.41
Abnormal regulation of immunoglobulin synthesis in vitro in primary biliary cirrhosis. Gastroenterology (1980) 1.36
NIH conference: Primary biliary cirrhosis: a model autoimmune disease. Ann Intern Med (1983) 1.35
Psychiatric complications of long-term interferon alfa therapy. Arch Intern Med (1987) 1.33
Hepatic coma due to acute hepatic necrosis treated by exchange blood-transfusion. Lancet (1967) 1.30
Comparing the anatomical consistency of the posterior superior iliac spine to the iliac crest as reference landmarks for the lumbopelvic spine: a retrospective radiological study. Clin Anat (2007) 1.29
Determination of influenzavirus neuraminidase inhibition titres. Bull World Health Organ (1975) 1.27
Oral acyclovir to suppress frequently recurrent herpes labialis. A double-blind, placebo-controlled trial. Ann Intern Med (1993) 1.27
Hypercatabolism of the third component of complement in patients with primary biliary cirrhosis. J Lab Clin Med (1976) 1.27
Isolation, structure and genetics of HLA-A, -B, -C and -DRw (Ia) antigens. Br Med Bull (1978) 1.27
Donor transaminase and recipient hepatitis. Impact on blood transfusion services. JAMA (1981) 1.24
Immunologic tolerance in lymphatic filariasis. Diminished parasite-specific T and B lymphocyte precursor frequency in the microfilaremic state. J Clin Invest (1992) 1.24
Quantitation of antibody to hepatitis A antigen by immune electron microscopy. Infect Immun (1976) 1.24
The effect of a new immunosuppressive drug, brequinar sodium, on heart, liver, and kidney allograft rejection in the rat. Transplantation (1992) 1.23
Cyclic hematopoiesis: the mechanism of cyclic neutropenia in grey collie dogs. J Clin Invest (1972) 1.23
A prospective trial of colchicine for primary biliary cirrhosis. N Engl J Med (1986) 1.22
Protein metabolism in the intestinal stagnant loop syndrome. Gut (1968) 1.21
Development of the Xenopus pronephric system. Dev Biol (1995) 1.20
Meiotic maturation in Xenopus oocytes: a link between the cessation of protein secretion and the polarized disappearance of Golgi apparati. J Cell Biol (1985) 1.20
Sjögren's syndrome in patients with primary biliary cirrhosis. Hepatology (1990) 1.19
Massive infection with Fasciola hepatica in man. Am J Med (1977) 1.19
Hepatic encephalopathy: molecular mechanisms underlying the clinical syndrome. J Neurol Sci (1999) 1.19
Addition of pathology and biomarker information significantly improves the performance of the Manchester scoring system for BRCA1 and BRCA2 testing. J Med Genet (2009) 1.18
Biliary secretion in a patient with cystic dilation of the intrahepatic biliary tree. Gastroenterology (1968) 1.18
Bacteraemia in association with hepatocellular and hepatobiliary disease. Postgrad Med J (1967) 1.16
Frequency of variant antigens in Giardia lamblia. Exp Parasitol (1990) 1.16
Serum complement in chronic liver disease. Gut (1973) 1.15
Randomized controlled trial of adenine arabinoside monophosphate for chronic type B hepatitis. Gastroenterology (1984) 1.14
The uptake of native and desialylated glucocerebrosidase by rat hepatocytes and Kupffer cells. Biochem Biophys Res Commun (1978) 1.14
A short course of prednisolone in chronic type B hepatitis. Report of a randomized, double-blind, placebo-controlled trial. Ann Intern Med (1986) 1.14
Studies on the particulate lactose synthetase of mouse mammary gland and the role of -lactalbumin in the initiation of lactose synthesis. Biochem J (1972) 1.13
A model of fulminant hepatic failure in the rabbit. Gastroenterology (1978) 1.12
Lipoprotein abnormalities in primary biliary cirrhosis. Association with hepatic lipase inhibition as well as altered cholesterol esterification. Gastroenterology (1985) 1.11
Infectivity of visna virus DNA. Virology (1976) 1.09
Clinical and serologic study of four smallpox vaccines comparing variations of dose and route of administration. Standard percutaneous revaccination of children who receive primary percutaneous vaccination. J Infect Dis (1977) 1.08
A controlled trial of naloxone infusions for the pruritus of chronic cholestasis. Gastroenterology (1992) 1.08
Deficiency of the autologous mixed lymphocyte reaction in patients with primary biliary cirrhosis. J Clin Invest (1980) 1.07
Genotype-dependent variability in flow cytometric evaluation of reduced nicotinamide adenine dinucleotide phosphate oxidase function in patients with chronic granulomatous disease. J Pediatr (1996) 1.07
Efficacy of intermittent colchicine therapy in familial Mediterranean fever. Ann Intern Med (1977) 1.07
Quantitative analysis of mononuclear cells expressing human immunodeficiency virus type 1 RNA in esophageal mucosa. J Exp Med (1994) 1.07
A comparative assessment of cartilage and joint fat pad as a potential source of cells for autologous therapy development in knee osteoarthritis. Rheumatology (Oxford) (2007) 1.07
The local effects of cachectin/tumor necrosis factor on wound healing. Ann Surg (1991) 1.07
Biosynthesis of the human C3b/C4b receptor during differentiation of the HL-60 cell line. Identification and characterization of a precursor molecule. J Clin Invest (1984) 1.06
In vitro cell-mediated cytotoxicity in primary biliary cirrhosis and chronic hepatitis. Dysfunction of spontaneous cell-mediated cytotoxicity in primary biliary cirrhosis. J Clin Invest (1977) 1.06
Hepatic encephalopathy and the gamma-aminobutyric-acid neurotransmitter system. Lancet (1982) 1.05
Prevention of catheter-associated urinary tract infections. Efficacy of daily meatal care regimens. Am J Med (1981) 1.05
Abnormal clearance of immune complexes from the circulation of patients with primary sclerosing cholangitis. Gastroenterology (1985) 1.05
Clinical and serologic study of four smallpox vaccines comparing variations of dose and route of administration. Primary percutaneous vaccination. J Infect Dis (1977) 1.05
An aflatoxin-associated mutational hotspot at codon 249 in the p53 tumor suppressor gene occurs in hepatocellular carcinomas from Mexico. Carcinogenesis (1996) 1.05
Dynamic coronary tone in precipitation, exacerbation and relief of angina pectoris. Am J Cardiol (1981) 1.05
Effects of naloxone infusions in patients with the pruritus of cholestasis. A double-blind, randomized, controlled trial. Ann Intern Med (1995) 1.04